Atopic Dermatitis-Like Skin Lesions Reduced by Topical Application and Intraperitoneal Injection of Hirsutenone in NC/Nga Mice

Atopic dermatitis (AD) is a common inflammatory skin disease. The increasing prevalence and severity of AD have prompted the developments of safer, more effective drugs. Although topical corticosteroids have been used as first line therapy for AD, their potential side effects limit their clinical applications. To investigate the effect of hirsutenone (HIR), a diarylheptanoid compound, on AD-like skin lesions and other factors related to immune response is the aim of this paper Th2-related cytokines (IL-4, IL-5, IL-13), eosinophil, IgE inflammatory factors (COX-2, iNOS) levels were reduced in blood, lymphocytes, and tissue after HIR treatment. These results suggest that HIR might be an effective treatment for AD.

[1]  S. Myung,et al.  Diarylheptanoid hirsutenone prevents tumor necrosis factor-alpha-stimulated production of inflammatory mediators in human keratinocytes through NF-kappaB inhibition. , 2009, International immunopharmacology.

[2]  Hee Yong Park,et al.  Suppression of T cell activation by hirsutenone, isolated from the bark of Alnus japonica, and its therapeutic advantages for atopic dermatitis. , 2009, European journal of pharmacology.

[3]  Oh-Hyung Kwon,et al.  Effect of 5-O-Methylhirsutanonol on nuclear factor-kappaB-dependent production of NO and expression of iNOS in lipopolysaccharide-induced RAW264.7 cells. , 2008, Journal of agricultural and food chemistry.

[4]  J. Lim,et al.  Effects of diarylheptanoids on the tumor necrosis factor-alpha-induced expression of adhesion molecules in human umbilical vein endothelial cells. , 2007, Journal of agricultural and food chemistry.

[5]  K. Yasui,et al.  A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. , 2007, Allergology international : official journal of the Japanese Society of Allergology.

[6]  N. Kawahara,et al.  New diarylheptanoids from Alnus japonica and their antioxidative activity. , 2005, Chemical & pharmaceutical bulletin.

[7]  H. V. Bever.  Recent advances in the pathogenesis of atopic dermatitis , 1992, European Journal of Pediatrics.

[8]  Min-Won Lee,et al.  Nitric oxide and prostaglandin E2 synthesis inhibitory activities of diarylheptanoids from the barks of Alnus japonica steudel. , 2005, Archives of pharmacal research.

[9]  Jung,et al.  New Diarylheptanoid from the Barks of Alnus japonica Steudel , 2005 .

[10]  W. Cookson.  The immunogenetics of asthma and eczema: a new focus on the epithelium , 2004, Nature Reviews Immunology.

[11]  H. Simon,et al.  Eosinophils and atopic dermatitis , 2004, Allergy.

[12]  D. Leung.  Immunopathology of atopic dermatitis , 2004, Springer Seminars in Immunopathology.

[13]  D. Thaçi.  Langzeitmanagement des atopischen Ekzems bei Kindern mit Calcineurininhibitoren , 2003 .

[14]  D. Thaçi.  [Long term management of childhood atopic dermatitis with calcineurin inhibitors]. , 2003, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[15]  H. Matsuda,et al.  Atopic Dermatitis-Like Skin Lesions Induced by Topical Application of Mite Antigens in NC/Nga Mice , 2001, International Archives of Allergy and Immunology.

[16]  H. Oku,et al.  Antipruritic and antidermatitic effect of extract and compounds of Impatiens balsamina L. in atopic dermatitis model NC mice , 2001, Phytotherapy research : PTR.

[17]  H. Nojima,et al.  Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis. , 2001, Journal of dermatological science.

[18]  C. Akdis,et al.  Immune regulation in atopic dermatitis. , 2000, Current opinion in immunology.

[19]  D. Tashkin,et al.  Alternative medicine for allergy and asthma. , 2000, The Journal of allergy and clinical immunology.

[20]  Y. C. Kim,et al.  Diarylheptanoids with in vitro inducible nitric oxide synthesis inhibitory activity from Alnus hirsuta. , 2000, Planta medica.

[21]  D. Strachan.  Family size, infection and atopy: the first decade of the 'hygiene hypothesis' , 2000, Thorax.

[22]  S. Higa,et al.  Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. , 2000, The Journal of allergy and clinical immunology.

[23]  J. H. Kim,et al.  Inhibition of cyclooxygenase-2 expression by diarylheptanoids from the bark of Alnus hirsuta var. sibirica. , 2000, Biological & pharmaceutical bulletin.

[24]  J. Britton,et al.  Annual report October 1998 to September 1999 , 2000, Thorax.

[25]  P. Askenase,et al.  Development of Atopic Dermatitis-like Skin Lesion with Ige Hyperproduction in Nc/nga Mice , 2022 .

[26]  A. Voragen,et al.  Complex Pectins: Structure elucidation using enzymes , 1996 .

[27]  J. Kim,et al.  Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. , 1995, Journal of immunology.

[28]  Q. Hamid,et al.  Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. , 1994, The Journal of clinical investigation.

[29]  M. Uehara,et al.  Descendant family history of atopic dermatitis. , 1993, Acta dermato-venereologica.

[30]  T. Hirano,et al.  Molecular regulation of B lymphocyte response. , 1988, Annual review of immunology.

[31]  U. Reinhold,et al.  Immunoglobulin E and immunoglobulin G subclass distribution in vivo and relationship to in vitro generation of interferon-gamma and neopterin in patients with severe atopic dermatitis. , 1988, International archives of allergy and applied immunology.

[32]  A. Collmer,et al.  Comparison of pectic enzymes produced by Erwinia chrysanthemi, Erwinia carotovora subsp. carotovora, and Erwinia carotovora subsp. atroseptica , 1986, Applied and environmental microbiology.

[33]  Y. Asakawa.  Chemical Constituents of Alnus firma (BETULACEAE). I. Phenyl Propane Derivatives Isolated from Alnus firma , 1970 .